1. Home
  2. IDAI vs KTTA Comparison

IDAI vs KTTA Comparison

Compare IDAI & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDAI
  • KTTA
  • Stock Information
  • Founded
  • IDAI 2016
  • KTTA 2020
  • Country
  • IDAI United States
  • KTTA United States
  • Employees
  • IDAI N/A
  • KTTA N/A
  • Industry
  • IDAI Computer Software: Prepackaged Software
  • KTTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • IDAI Technology
  • KTTA Health Care
  • Exchange
  • IDAI Nasdaq
  • KTTA Nasdaq
  • Market Cap
  • IDAI 4.9M
  • KTTA 5.1M
  • IPO Year
  • IDAI N/A
  • KTTA 2021
  • Fundamental
  • Price
  • IDAI $3.04
  • KTTA $0.69
  • Analyst Decision
  • IDAI
  • KTTA
  • Analyst Count
  • IDAI 0
  • KTTA 0
  • Target Price
  • IDAI N/A
  • KTTA N/A
  • AVG Volume (30 Days)
  • IDAI 40.7K
  • KTTA 116.0K
  • Earning Date
  • IDAI 08-12-2025
  • KTTA 08-12-2025
  • Dividend Yield
  • IDAI N/A
  • KTTA N/A
  • EPS Growth
  • IDAI N/A
  • KTTA N/A
  • EPS
  • IDAI N/A
  • KTTA N/A
  • Revenue
  • IDAI $3,054,143.00
  • KTTA N/A
  • Revenue This Year
  • IDAI $65.46
  • KTTA N/A
  • Revenue Next Year
  • IDAI $12.00
  • KTTA N/A
  • P/E Ratio
  • IDAI N/A
  • KTTA N/A
  • Revenue Growth
  • IDAI N/A
  • KTTA N/A
  • 52 Week Low
  • IDAI $1.43
  • KTTA $0.65
  • 52 Week High
  • IDAI $18.75
  • KTTA $7.50
  • Technical
  • Relative Strength Index (RSI)
  • IDAI 56.45
  • KTTA 37.92
  • Support Level
  • IDAI $2.60
  • KTTA $0.68
  • Resistance Level
  • IDAI $2.94
  • KTTA $0.79
  • Average True Range (ATR)
  • IDAI 0.20
  • KTTA 0.04
  • MACD
  • IDAI -0.02
  • KTTA 0.00
  • Stochastic Oscillator
  • IDAI 59.58
  • KTTA 12.51

About IDAI T Stamp Inc.

T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility. The artificial intelligence-powered solutions segment generates revenue principally from software licenses, professional services, and recurring Software-as-a-Service ("SaaS") revenue.

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

Share on Social Networks: